Screener
Zevra Therapeutics, Inc. ZVRA Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
| Line item | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Non-cash lease expense | 240 | — |
| Non-cash interest expense | 342 | 1,352 |
| Fair value adjustment related to warrant and CVR liability | 5,440 | (4,127) |
| Accretion on investments | (1,219) | (1,060) |
| Fair value adjustment related to investments | 356 | 5 |
| Loss on extinguishment of debt | 2,756 | — |
| Loss on derivative liability | 7,216 | — |
| Cash paid to settle derivative instrument and payoff premium | (9,016) | — |
ITEM 1.FINANCIAL STATEMENTS
FAQ
- What is Zevra Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Zevra Therapeutics, Inc. (ZVRA) reported accretion (amortization) of discounts and premiums, investments of $595K in Q2 2026.
- How has Zevra Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Zevra Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 21.2% year-over-year, from $755K to $595K.
- What does accretion (amortization) of discounts and premiums, investments mean?
- Measures the non-cash adjustment to the carrying value of investment securities to reflect the amortization of premiums or accretion of discounts over the life of the instrument. This adjustment aligns the reported interest income with the effective interest method, impacting the reconciliation of net income to cash flow.
Ask your AI about Zevra Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude